US Patent 11787802 Dihydrobenzimidazolones for medical treatment
Patent 11787802 was granted and assigned to C4 Therapeutics on October, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 14, 2022
Date of Patent
October 17, 2023
Patent Applicant
Patent Application Number
17576582
Patent Inventor Names
Roger Norcross
Eric Andre Kusznir
Annick Goergler
Fabian Dey
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11787802 Dihydrobenzimidazolones for medical treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.